Piramal Pharma Solutions announces completion of new lab facility

Anchored by a world-class R&D center, the cGMP kilo lab facility at Ennore will bridge the gap between discovery and early clinical development.

TNN
Advt.

MUMBAI: Piramal Pharma Solutions (PPS), a contract development and manufacturing organization, announced the completion of its new cGMP kilo lab suite at its API (Active Pharmaceutical Ingredient) site in Ennore (Chennai). The suite will formally open on December 1, says a company statement.

Ennore is a key API site in the PPS integrated site network, with capabilities from early development through commercial manufacturing, with an available capacity of over 300kL. The site supplies key starting materials, registered starting materials, advanced intermediates and APIs for both large pharma and biotech firms, in North America, Europe, and RoW markets.

Anchored by a world-class R&D center, the cGMP kilo lab facility at Ennore will bridge the gap between discovery and early clinical development, addressing the needs of several discovery customers that want to rapidly advance their programs into the clinic, it adds.

Subsequent development and manufacturing of APIs as the programs advance, can be carried out at the Piramal sites in Riverview (US), Aurora (Canada), Digwal (India), in addition to Ennore.

LEAVE A REPLY

Please enter your comment!
Please enter your name here